Hyperfine

Closed (deSPAC)

Profile in progress

What it is: Hyperfine, Inc
What it’s doing now: Merging with HealthCor Catalio Acquisition Corp. (HCAQ) — closed (despac).
What you should know: Data is still being assembled for this company — what is shown below is everything we have verified so far.

The business, per its filings

SEC primary

Hyperfine, Inc. is the groundbreaking medical device company that created Swoop®, the world’s first FDA-cleared portable MRI system. Hyperfine designed Swoop to enable rapid diagnoses and treatment for every patient regardless of income, resources, or location, pushing the boundaries of conventional imaging technology and expanding patient access to life-saving care. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength, allowing clinicians to quickly scan, diagnose, and treat patients in various clinical settings. Swoop can be wheeled directly to the patient’s bedside, plugged into a standard electrical wall outlet, and controlled by an iPad®. Designed as a complementary system to conventional MRIs at a fraction of the cost, Swoop captures images in minutes, providing critical decision-making capabilities in emergency departments, operating rooms outside the sterile field, and intensive care units, among others.

What the company says about itself

Web research — not audited

Hyperfine, Inc. provides the Swoop® Portable MR Imaging System, an AI-powered, portable brain MRI that uses a magnet with a fraction of the field strength used in conventional MRI. The system is designed to be brought to the point of care, offering diagnostic-quality imaging in settings such as hospitals (ICU and emergency departments), neurology clinics, and pediatrics. It features Optive AI™ software for image reconstruction and is described as safe, comfortable, and requiring no dedicated staff or infrastructure.

Markets:: Healthcare | Medical Imaging | Stroke Care | Neurology | Pediatrics
Products:: Swoop® Portable MR Imaging System | Optive AI™ software

What our web check found

[WEB-INTEL 2026-08-26] 1 finding(s) · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "The medical device company announced it has priced an underwritten public offering of 14 million shares of its Class A common stock at $1.25 per share." [https://www.investing.com/news/stock-market-news/hyperfine-stock-plunges-after-pricing-public-offering-at-125-per-share-93CH-4292592#:~:text=The%20medical%20device%20company%20announced,stock%20at%20%241.25%20per%20share.]

Source: https://www.hyperfinemri.com/ · captured Aug 26, 2026 · marketing claims are reported as claims, never merged into the filed figures above.

The deal it’s entering

Hyperfine is merging with HealthCor Catalio Acquisition Corp. (HCAQ) currently marked Closed (deSPAC).

Headline equity value

—

How to read these numbers: headline vs effective valuation · what a definitive agreement commits

What exactly is being valued, and at what

Common questions

Is Hyperfine going public?

Hyperfine has an approved merger with the SPAC HealthCor Catalio Acquisition Corp. (HCAQ). Deal status: Closed (deSPAC).

Does Hyperfine have revenue?

The filings we've parsed don't state a usable revenue figure yet; this profile is updated as new documents land.

Educational content, not investment advice.